LearnGlossaryMarketStocksSuperinvestorsSign in

DXR

Daxor Corporation

Healthcare · $66M market cap

Verdict

Share price

$10.62

close of Oct 3, 2026

Fair value

$19.84

Sticker Price

Payback Price

$7.94

buy price

Undervalued

DXR is Undervalued: at $10.62 it trades 46% below its fair value of $19.84. Its buy price (Payback Price) is $7.94, 25% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.

How we valued it

Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth-2.3% a year✗
Equity per share growth-5.1% a year✗
Sales growth0.5% a year✗
Free cash flow growth-35.5% a year✗
Return on invested capital7.6%✗

Follow DXR

Get notified when it reaches its buy price of $7.94. Free.

Create a free account

Insider activity

Since Jun 23, 2026: no open-market purchases and 8 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

Jefferies John

Chief Medical Officer · 2026-08-28

Award

2,451 shares

DesRosiers Caleb

director · 2026-06-23

Award

$25K

Feuer Edward

director · 2026-06-23

Award

$25K

Cremisi Henry D.

director · 2026-06-23

Award

$25K

Goudie Joy S.

director · 2026-06-23

Award

$25K

Show all 8 other filings

Feldschuh Jonathan Adam

Chief Scientific Officer · 2026-06-23

Award

25,000 shares

Feldschuh Michael Richard

Chief Executive Officer · 2026-06-23

Award

30,000 shares

Michel Robert J

Chief Financial Officer · 2026-06-23

Award

12,000 shares

About Daxor Corporation

Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is…

Medical - Instruments & Supplies

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works